Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
- 1 January 1996
- book chapter
- Published by Elsevier in Advances in Cancer Research
- Vol. 68, 67-108
- https://doi.org/10.1016/s0065-230x(08)60352-8
Abstract
No abstract availableThis publication has 180 references indexed in Scilit:
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- MDM2 gene amplification in human breast cancerEuropean Journal Of Cancer, 1994
- Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neckEuropean Journal Of Cancer, 1993
- Unexpected Prad-1 amplification in multiple simultaneous localisations of squamous cell carcinoma of the head and neckEuropean Journal Of Cancer, 1993
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Association between chromosome 11q13 amplification and prognosis of patients with oesophageal carcinomasEuropean Journal Of Cancer, 1992
- Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptorsEuropean Journal Of Cancer, 1992
- Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomasInternational Journal of Cancer, 1991
- Two homologous oncogenes, HST1 and INT2, are closely located in human genomeBiochemical and Biophysical Research Communications, 1988
- A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinomaNature, 1987